C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/12 (2006.01) A61K 31/42 (2006.01) A61K 31/425 (2006.01) A61K 31/435 (2006.01) A61K 31/495 (2006.01) A61K 31/53 (2006.01) A61K 31/535 (2006.01) A61K 31/54 (2006.01) A61K 31/55 (2006.01) A61K 31/675 (2006.01) A61K 31/695 (2006.01) C07D 261/04 (2006.01) C07D 261/08 (2006.01) C07D 261/10 (2006.01) C07D 413/00 (2006.01) C07D 413/04 (2006.01) C07D 413/06 (2006.01) C07D 413/10 (2006.01) C07D 453/02 (2006.01) C07D 455/02 (2006.01) C07D 471/04 (2006.01) C07D 473/00 (2006.01) C07D 475/00 (2006.01) C07D 487/0
Patent
CA 2222147
This invention relates to novel isoxazolines and isoxazoles which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex or the vitronectin receptor, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds, alone or in combination with other therapeutic agents, for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders.
L'invention porte sur de nouvelles isoxazolines et isoxazoles servant d'antagonistes du complexe récepteur du fibrinogène des glycoprotéines IIb/IIIa plaquettaires, ou du récepteur de la vitronectine, sur des préparations pharmaceutiques contenant lesdits composés, sur leurs procédés de préparation, et sur leurs méthodes d'utilisation, seuls ou en association avec d'autres agents thérapeutiques, comme inhibiteurs de l'agrégation plaquettaire, comme thrombolytiques, et/ou pour le traitement d'affections de caractère thrombo-embolique.
Batt Douglas Guy
Cain Gary Avonn
Degrado William Frank
Hussain Munir Alwan
Mousa Shaker Ahmed
Bristol-Myers Squibb Pharma Company
Dimock Stratton Llp
The Dupont Merck Pharmaceutical Company
LandOfFree
Novel isoxazoline and isoxazole fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel isoxazoline and isoxazole fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel isoxazoline and isoxazole fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1755140